[go: up one dir, main page]

IT1264447B1 - Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di - Google Patents

Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di

Info

Publication number
IT1264447B1
IT1264447B1 IT93MI000985A ITMI930985A IT1264447B1 IT 1264447 B1 IT1264447 B1 IT 1264447B1 IT 93MI000985 A IT93MI000985 A IT 93MI000985A IT MI930985 A ITMI930985 A IT MI930985A IT 1264447 B1 IT1264447 B1 IT 1264447B1
Authority
IT
Italy
Prior art keywords
cells
pheocromocytoma
ntrki
oncogens
screening
Prior art date
Application number
IT93MI000985A
Other languages
English (en)
Inventor
Angela Greco
Marco A Pierotti
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Publication of ITMI930985A0 publication Critical patent/ITMI930985A0/it
Priority to IT93MI000985A priority Critical patent/IT1264447B1/it
Priority to DE69402313T priority patent/DE69402313T2/de
Priority to DK94917613.5T priority patent/DK0698096T3/da
Priority to AU69269/94A priority patent/AU689778B2/en
Priority to PCT/EP1994/001509 priority patent/WO1994026889A2/en
Priority to JP52495294A priority patent/JP3549536B2/ja
Priority to ES94917613T priority patent/ES2101537T3/es
Priority to CA002162677A priority patent/CA2162677C/en
Priority to AT94917613T priority patent/ATE150790T1/de
Priority to NZ267086A priority patent/NZ267086A/en
Priority to FI955447A priority patent/FI955447L/fi
Priority to EP94917613A priority patent/EP0698096B1/en
Publication of ITMI930985A1 publication Critical patent/ITMI930985A1/it
Priority to NO19954556A priority patent/NO319374B1/no
Application granted granted Critical
Publication of IT1264447B1 publication Critical patent/IT1264447B1/it
Priority to GR970401521T priority patent/GR3023878T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Si descrivono cellule neuronali caratterizzate dal fatto che comprendono un gene che codifica per un derivato oncogenico del recettore NTRK1 di NGF, detto gene provocando differenziazione neuronale di dette cellule in assenza di NGF.
IT93MI000985A 1993-05-14 1993-05-14 Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di IT1264447B1 (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT93MI000985A IT1264447B1 (it) 1993-05-14 1993-05-14 Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di
ES94917613T ES2101537T3 (es) 1993-05-14 1994-05-10 Expresion de oncogenes derivados de ntrk1 en celulas de feocromocitoma pc12 y uso de los mismos para el rastreo de compuestos anti-tirosina quinasa.
AT94917613T ATE150790T1 (de) 1993-05-14 1994-05-10 Expression von ntrki-abgeleiteten oncogenen in pciz pheochromocytomazellen und ihre verwendung im aufspüren von anti-tyrosinkinase-verbindungen
AU69269/94A AU689778B2 (en) 1993-05-14 1994-05-10 Expression of NTRK1-derived oncogenes in PC12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
PCT/EP1994/001509 WO1994026889A2 (en) 1993-05-14 1994-05-10 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
JP52495294A JP3549536B2 (ja) 1993-05-14 1994-05-10 神経単位細胞、神経単位細胞取得方法および化合物のスクリーニング方法
DE69402313T DE69402313T2 (de) 1993-05-14 1994-05-10 Expression von ntrki-abgeleiteten oncogenen in pciz pheochromocytomazellen und ihre verwendung im aufspüren von anti-tyrosinkinase-verbindungen
CA002162677A CA2162677C (en) 1993-05-14 1994-05-10 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
DK94917613.5T DK0698096T3 (da) 1993-05-14 1994-05-10 Ekspression af NTRK1-afledte onkogener i PC12-fæokromocytomceller og anvendelse deraf til screening af anti-tyrosinkinaseforbindelser.
NZ267086A NZ267086A (en) 1993-05-14 1994-05-10 Ngf receptor ntrk1 gene-containing neuronal cells
FI955447A FI955447L (fi) 1993-05-14 1994-05-10 NTRK1-peräisten onkogeenien ilmentäminen PC12-feokromosytoomasoluissa ja niiden käyttö anti-tyrosiinikinaasiyhdisteiden seulomiseksi
EP94917613A EP0698096B1 (en) 1993-05-14 1994-05-10 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds
NO19954556A NO319374B1 (no) 1993-05-14 1995-11-13 Neuronale celler med et gen som koder for et onkogent derivat av NGF-reseptoren NTRK1, fremgangsmate for a fremskaffe slike celler, og anvendelse av cellene for utvelgelse av anti-tyrosin-kinase-forbindelser
GR970401521T GR3023878T3 (en) 1993-05-14 1997-06-25 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI000985A IT1264447B1 (it) 1993-05-14 1993-05-14 Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di

Publications (3)

Publication Number Publication Date
ITMI930985A0 ITMI930985A0 (it) 1993-05-14
ITMI930985A1 ITMI930985A1 (it) 1994-11-14
IT1264447B1 true IT1264447B1 (it) 1996-09-23

Family

ID=11366164

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI000985A IT1264447B1 (it) 1993-05-14 1993-05-14 Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di

Country Status (13)

Country Link
EP (1) EP0698096B1 (it)
JP (1) JP3549536B2 (it)
AT (1) ATE150790T1 (it)
AU (1) AU689778B2 (it)
DE (1) DE69402313T2 (it)
DK (1) DK0698096T3 (it)
ES (1) ES2101537T3 (it)
FI (1) FI955447L (it)
GR (1) GR3023878T3 (it)
IT (1) IT1264447B1 (it)
NO (1) NO319374B1 (it)
NZ (1) NZ267086A (it)
WO (1) WO1994026889A2 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696404B2 (en) 1996-08-19 2010-04-13 Advanced Cell Technology, Inc. Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
WO2001016304A2 (en) * 1999-08-27 2001-03-08 Ec (European Community) Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing
EP2336297A3 (en) 1999-10-28 2011-11-16 University of Massachusetts Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
AU2002245210B2 (en) 2001-01-02 2007-06-21 Stemron Inc. A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype
DE10300015A1 (de) 2003-01-03 2004-07-15 Aventis Pharma Deutschland Gmbh Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen
WO2013059740A1 (en) 2011-10-21 2013-04-25 Foundation Medicine, Inc. Novel alk and ntrk1 fusion molecules and uses thereof
WO2013143467A1 (zh) * 2012-03-27 2013-10-03 中国科学院上海生命科学研究院 孤雄单倍体干细胞系及其制法和应用
HK1214830A1 (zh) 2012-11-05 2016-08-05 Foundation Medicine, Inc. 新型ntrk1融合分子及其应用
EP4223770A3 (en) 2012-11-05 2023-10-18 Foundation Medicine, Inc. Novel fusion molecules and uses thereof
AU2014207342C1 (en) 2013-01-18 2019-04-04 Foundation Medicine, Inc. Methods of treating cholangiocarcinoma

Also Published As

Publication number Publication date
FI955447A7 (fi) 1995-11-13
ITMI930985A0 (it) 1993-05-14
NZ267086A (en) 1997-01-29
JPH08510119A (ja) 1996-10-29
ATE150790T1 (de) 1997-04-15
GR3023878T3 (en) 1997-09-30
DE69402313D1 (de) 1997-04-30
AU6926994A (en) 1994-12-12
EP0698096B1 (en) 1997-03-26
FI955447A0 (fi) 1995-11-13
NO319374B1 (no) 2005-07-25
WO1994026889A3 (en) 1994-12-22
NO954556D0 (no) 1995-11-13
ES2101537T3 (es) 1997-07-01
DK0698096T3 (da) 1997-10-27
WO1994026889A2 (en) 1994-11-24
EP0698096A1 (en) 1996-02-28
JP3549536B2 (ja) 2004-08-04
FI955447L (fi) 1995-11-13
AU689778B2 (en) 1998-04-09
DE69402313T2 (de) 1997-08-21
ITMI930985A1 (it) 1994-11-14
NO954556L (no) 1996-01-12

Similar Documents

Publication Publication Date Title
NO942858L (no) Nye polypeptider med granulocyt-koloni-stimulerende aktivitet, deres fremstilling samt farmasöytiske prepatater inneholdende polypeptidene
ATE407362T1 (de) Screening von verbindungen zu ihrer fähigkeit um die herstellung von beta-amyloid peptiden zu veränderen
ES2101962T3 (es) La elucidacion y sintesis de las fenetilamidas de tetrapeptidos antineoplasticos del dolastatin 10.
DE68906898D1 (de) Kraftstoffsteuerungssystem.
IT1264447B1 (it) Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di
DE69634303D1 (de) Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
DE68907020D1 (de) Hydraulisches steuersystem.
DK289285A (da) Thymopentin analoge
DK0778890T3 (da) DNA, som koder for en human calciumkanal-alpha-1E-underenhed
DE68919248D1 (de) Prozessregelungssystem.
NO882897D0 (no) Avleveringssystem for legemidler.
ATE182628T1 (de) Ein protein, das spezifische dna-strukturen erkennt, und seine verwendungen
DK27885A (da) Fremstilling af peptider
DE69628566D1 (de) Neurale transplantation durch verwendung von pluripotenten neuroepithelzellen
DE68907053D1 (de) Grundierungs/membranabdichtungssystem.
ATE179181T1 (de) Multifunktionelle neurotrophe faktoren
FI880588A0 (fi) Interpolymerkompositioner och membraner av eten-akrylsyratyp, vilka har foerbaettrad glidbarhet och foerminskad faestfoermaoga.
DE69228665D1 (de) Eukaryotisches Expressionssystem
DE3886950D1 (de) Platin-verbindungen, geeignet zur verwendung als arzneimittel.
NO954081L (no) Cytotoksisk faktor forbundet med disseminert sklerose, dens påvisning og kvantifisering
IL110585A0 (en) Tripeptides, their preparation and pharmaceutical compositions containing them
ES2015241A4 (es) Procedimiento para clarificacion del mosto de uvas y mosto obtenido por este procedimiento.
FI894211A0 (fi) Mikrobiologiskt foerfarande foer framstaellning av agrokemiskt anvaendbara aktivaemnen.
GB1503856A (en) Pharmaceutical composition containing trimethoprim sulphamethoxazole and alpha-amylase
DE59807167D1 (de) Zellenrad zur Uebergabe von Gegenständen von einem ersten Fördermittel an ein zweites Fördermittel

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970529